Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / ADS
-
Total 13F shares
-
26,039,068
-
Share change
-
+2,514,124
-
Total reported value
-
$29,160,000
-
Price per share
-
$1.12
-
Number of holders
-
30
-
Value change
-
+$2,339,195
-
Number of buys
-
11
-
Number of sells
-
18
Institutional Holders of ASLAN PHARMACEUTICALS LTD - ADS (ASLN) as of Q4 2021
As of 31 Dec 2021,
ASLAN PHARMACEUTICALS LTD - ADS (ASLN) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,039,068 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, Vivo Capital, LLC, CITADEL ADVISORS LLC, MANGROVE PARTNERS, TANG CAPITAL MANAGEMENT LLC, ORBIMED ADVISORS LLC, Temasek Holdings (Private) Ltd, MILLENNIUM MANAGEMENT LLC, SILVERARC CAPITAL MANAGEMENT, LLC, and Sio Capital Management, LLC.
This page lists
30
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.